AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study
Authors: Alexopoulos, A Kouroussis, C Malamos, N Kakolyris, S Kalbakis, K Kosmas, C Mavroudis, D Agelaki, S Vlachonicolis, J Sarra, E Rigatos, G Georgoulias, V
Citation: A. Alexopoulos et al., Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study, ANN ONCOL, 12(6), 2001, pp. 793-798
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer
Authors: Mavroudis, D Papadakis, E Veslemes, M Tsiafaki, X Stavrakakis, J Kouroussis, C Kakolyris, S Bania, E Jordanoglou, J Agelidou, M Vlachonicolis, J Georgoulias, V
Citation: D. Mavroudis et al., A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, ANN ONCOL, 12(4), 2001, pp. 463-470
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
Authors: Kakolyris, S Mavroudis, D Tsavaris, N Souglakos, J Tsiafaki, P Kalbakis, K Agelaki, S Androulakis, N Georgoulias, V
Citation: S. Kakolyris et al., Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study, ANN ONCOL, 12(2), 2001, pp. 193-197
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer
Authors: Stathopoulos, GP Mavroudis, D Tsavaris, N Kouroussis, C Aravantinos, G Agelaki, S Kakolyris, S Rigatos, SK Karabekios, S Georgoulias, V
Citation: Gp. Stathopoulos et al., Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer, ANN ONCOL, 12(1), 2001, pp. 101-103
Transient fungemia due to Rhodotorula rubra in a cancer patient: Case report and review of the literature
Authors: Samonis, G Anatoliotaki, M Apostolakou, H Maraki, S Mavroudis, D Goergoulias, V
Citation: G. Samonis et al., Transient fungemia due to Rhodotorula rubra in a cancer patient: Case report and review of the literature, INFECTION, 29(3), 2001, pp. 173-176
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors
Authors: Kouroussis, C Kakolyris, S Mavroudis, D Androulakis, N Kalbakis, K Agelaki, S Sarra, E Souglakos, J Christodoulakis, M Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 404-407
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer
Authors: Agelaki, S Kakolyris, S Palamidas, P Kouroussis, C Mavroudis, D Kalbakis, K Georgoulias, V Raptis, A
Citation: S. Agelaki et al., A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer, LUNG CANC, 34(1), 2001, pp. 133-139
A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors
Authors: Kakolyris, S Kouroussis, C Souglakos, J Mavroudis, D Agelaki, S Kalbakis, K Androulakis, N Vardakis, N Vamvakas, L Georgoulias, V
Citation: S. Kakolyris et al., A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors, ONCOL-BASEL, 61(4), 2001, pp. 265-270
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study
Authors: Kouroussis, C Souglakos, J Kakolyris, S Mavroudis, D Malamos, N Kalbakis, K Androulakis, N Agelaki, A Vardakis, N Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study, ONCOL-BASEL, 61(1), 2001, pp. 36-41
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer
Authors: Kakolyris, S Souglakos, J Kouroussis, C Androulakis, N Mavroudis, D Kalbakis, K Kotsakis, A Vardakis, N Koukourakis, M Romanos, J Georgoulias, V
Citation: S. Kakolyris et al., A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer, ONCOL-BASEL, 60(3), 2001, pp. 207-213
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes
Authors: Kalbakis, K Kouroussis, C Kakolyris, S Mavroudis, D Souglakos, J Agelaki, S Vamvakas, L Christodoulakis, M Stylianou, K Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study
Authors: Giannakakis, T Ziras, N Kakolyris, S Mavroudis, D Androulakis, N Agelaki, S Parashos, M Sarra, E Dimou, T Hatzidaki, D Vlachonikolis, J Georgoulias, V
Citation: T. Giannakakis et al., Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study, EUR J CANC, 36(6), 2000, pp. 742-747
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
Authors: Kakolyris, S Kouroussis, C Kalbakis, K Mavroudis, D Souglakos, J Vardakis, N Kremos, S Georgoulias, V
Citation: S. Kakolyris et al., Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin, ANN ONCOL, 11(6), 2000, pp. 757-760
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study
Authors: Mavroudis, D Alexopoulos, A Ziras, N Malamos, N Kouroussis, C Kakolyris, S Agelaki, S Kalbakis, K Tsavaris, N Potamianou, A Rigatos, G Georgoulias, V
Citation: D. Mavroudis et al., Front-line treatment of advanced breast cancer with docetaxel and epirubicin: A multicenter phase II study, ANN ONCOL, 11(10), 2000, pp. 1249-1254
A dose escalation study of weekly docetaxel in patients with advanced solid tumors
Authors: Kouroussis, C Agelaki, S Mavroudis, D Souglakos, J Kakolyris, S Kalbakis, K Vardakis, N Reppa, D Hatzidaki, D Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose escalation study of weekly docetaxel in patients with advanced solid tumors, CANC CHEMOT, 46(6), 2000, pp. 488-492
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial
Authors: Mavroudis, D Kourousis, C Androulakis, N Kalbakis, K Agelaki, S Kakolyris, S Souglakos, J Sarra, E Vardakis, N Hatzidaki, D Sarmonis, G Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
Authors: Kakolyris, S Souglakos, J Agelaki, S Kourousis, C Mavroudis, D Sarra, E Malliotakis, P Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
Authors: Mavroudis, D Kourousis, C Kakolyris, S Agelaki, S Kalbakis, K Androulakis, N Souglakos, J Vardakis, N Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report, SEMIN ONCOL, 27(1), 2000, pp. 25-30
Prevention of acute graft-versus-host disease by delayed or selected lymphocyte add back
Authors: Barrett, J Mavroudis, D
Citation: J. Barrett et D. Mavroudis, Prevention of acute graft-versus-host disease by delayed or selected lymphocyte add back, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 435-446
Separating GVHD and GVL reactions
Authors: Mavroudis, D Barrett, J
Citation: D. Mavroudis et J. Barrett, Separating GVHD and GVL reactions, BAS CLIN ON, 22, 2000, pp. 285-306
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study
Authors: Kouroussis, C Xydakis, E Potamianou, A Giannakakis, T Kakolyris, S Agelaki, S Sara, E Malamos, N Alexopoulos, A Mavroudis, D Samonis, G Papadouris, S Georgoulias, V Panagos, G
Citation: C. Kouroussis et al., Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: A multicenter dose-escalation study, ANN ONCOL, 10(5), 1999, pp. 547-552
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
Authors: Mavroudis, D Malamos, N Alexopoulos, A Kourousis, C Agelaki, S Sarra, E Potamianou, A Kosmas, C Rigatos, G Giannakakis, T Kalbakis, K Apostolaki, F Vlachonicolis, J Kakolyris, S Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer
Authors: Kouroussis, C Androulakis, N Kakolyris, S Souglakos, J Kotsakis, T Mavroudis, D Katsogridakis, K Vardakis, N Hatzidaki, D Samonis, G Vlachonikolis, J Georgoulias, V
Citation: C. Kouroussis et al., Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer, J CL ONCOL, 17(3), 1999, pp. 862-869
High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients
Authors: Raptis, A Mavroudis, D Suffredini, AF Molldrem, J Van Rhee, F Childs, R Phang, S Barrett, AJ
Citation: A. Raptis et al., High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients, BONE MAR TR, 24(8), 1999, pp. 879-883
A technique for dual determination of cytotoxic and helper lymphocyte precursor frequency by a miniaturized dye release method
Authors: Hensel, N Agarwala, V Jiang, YZ Mavroudis, D Molldrem, J Barrett, AJ
Citation: N. Hensel et al., A technique for dual determination of cytotoxic and helper lymphocyte precursor frequency by a miniaturized dye release method, BONE MAR TR, 23(1), 1999, pp. 71-78
Risultati: 1-25 | 26-26